Clinical Trial: LineMatrix(R) Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733076) titled 'LineMatrix(R) Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement' on July 21.

Brief Summary: Single center, single arm study to evaluate the Safety and Efficacy of LineMatrix(R) Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Peripheral Arterial Disease

Intervention: DEVICE: LineMatrix(R) Biological Vascular Graft

LineMatrix(R) Biological Vascular Graft for Infrarenal Arterial Bypass or Replacement

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai Zhongshan Hospital

Published by HT Digital Content Services...